Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Novel Delivery Systems for Checkpoint Inhibitors.

Lamichhane P, Deshmukh R, Brown JA, Jakubski S, Parajuli P, Nolan T, Raja D, Badawy M, Yoon T, Zmiyiwsky M, Lamichhane N.

Medicines (Basel). 2019 Jul 11;6(3). pii: E74. doi: 10.3390/medicines6030074. Review.


Multicriteria optimization: Site-specific class solutions for VMAT plans.

Guerrero M, Fellows Z, Mohindra P, Badiyan S, Lamichhane N, Snider JW, Chen S.

Med Dosim. 2019 May 15. pii: S0958-3947(19)30052-4. doi: 10.1016/j.meddos.2019.04.003. [Epub ahead of print]


Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT.

Mohindra P, Sawant A, Griffin RJ, Lamichhane N, Vlashi E, Xu-Welliver M, Dominello M, Joiner MC, Burmeister J.

J Appl Clin Med Phys. 2019 Mar;20(3):7-13. doi: 10.1002/acm2.12545. Epub 2019 Feb 22. No abstract available.


Checkpoint Inhibition: Will Combination with Radiotherapy and Nanoparticle-Mediated Delivery Improve Efficacy?

Lamichhane P, Amin NP, Agarwal M, Lamichhane N.

Medicines (Basel). 2018 Oct 23;5(4). pii: E114. doi: 10.3390/medicines5040114. Review.


Dosimetric analysis of stereotactic body radiation therapy for pancreatic cancer using MR-guided Tri-60Co unit, MR-guided LINAC, and conventional LINAC-based plans.

Ramey SJ, Padgett KR, Lamichhane N, Neboori HJ, Kwon D, Mellon EA, Brown K, Duffy M, Victoria J, Dogan N, Portelance L.

Pract Radiat Oncol. 2018 Sep - Oct;8(5):e312-e321. doi: 10.1016/j.prro.2018.02.010. Epub 2018 Mar 1. No abstract available.


Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery.

Lamichhane N, Udayakumar TS, D'Souza WD, Simone CB 2nd, Raghavan SR, Polf J, Mahmood J.

Molecules. 2018 Jan 30;23(2). pii: E288. doi: 10.3390/molecules23020288. Review.


Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study.

Chinea FM, Patel VN, Kwon D, Lamichhane N, Lopez C, Punnen S, Kobetz EN, Abramowitz MC, Pollack A.

Oncotarget. 2017 Jul 6;8(41):69709-69721. doi: 10.18632/oncotarget.19068. eCollection 2017 Sep 19.


18F-Labeled Carboplatin Derivative for PET Imaging of Platinum Drug Distribution.

Lamichhane N, Dewkar GK, Sundaresan G, Wang L, Jose P, Otabashi M, Morelle JL, Farrell N, Zweit J.

J Nucl Med. 2017 Dec;58(12):1997-2003. doi: 10.2967/jnumed.117.191965. Epub 2017 Jul 20.


[18F]-Fluorinated Carboplatin and [111In]-Liposome for Image-Guided Drug Delivery.

Lamichhane N, Dewkar GK, Sundaresan G, Mahon RN, Zweit J.

Int J Mol Sci. 2017 May 18;18(5). pii: E1079. doi: 10.3390/ijms18051079.


Quantitative imaging: Correlating image features with the segmentation accuracy of PET based tumor contours in the lung.

Johnson PB, Young LA, Lamichhane N, Patel V, Chinea FM, Yang F.

Radiother Oncol. 2017 May;123(2):257-262. doi: 10.1016/j.radonc.2017.03.008. Epub 2017 Apr 20.


Going the distance: validation of Acuros and AAA at an extended SSD of 400 cm.

Lamichhane N, Patel VN, Studenski MT.

J Appl Clin Med Phys. 2016 Mar 8;17(2):63-73. doi: 10.1120/jacmp.v17i2.5913.


Intrinsically radiolabelled [(59)Fe]-SPIONs for dual MRI/radionuclide detection.

Hoffman D, Sun M, Yang L, McDonagh PR, Corwin F, Sundaresan G, Wang L, Vijayaragavan V, Thadigiri C, Lamichhane N, Zweit J.

Am J Nucl Med Mol Imaging. 2014 Sep 6;4(6):548-60. eCollection 2014.


Microfluidic radiosynthesis and biodistribution of [18 F] 2-(5-fluoro-pentyl)-2-methyl malonic acid.

Dewkar GK, Sundaresan G, Lamichhane N, Hirsch J, Thadigiri C, Collier T, Hartman MC, Vaidyanthan G, Zweit J.

J Labelled Comp Radiopharm. 2013 May 15;56(5):289-94. doi: 10.1002/jlcr.3016. Epub 2013 Feb 12.


Synthesis and characterization of intrinsically radiolabeled quantum dots for bimodal detection.

Sun M, Hoffman D, Sundaresan G, Yang L, Lamichhane N, Zweit J.

Am J Nucl Med Mol Imaging. 2012;2(2):122-35. Epub 2012 Mar 28.

Supplemental Content

Loading ...
Support Center